Pruritus to anticancer agents targeting the EGFR, BRAF, and CTLA-4.
about
Immune-mediated adverse events of anticytotoxic T lymphocyte-associated antigen 4 antibody therapy in metastatic melanoma.Managing the skin toxicities from new melanoma drugs.Dermatologic Reactions to Targeted Therapy: A Focus on Epidermal Growth Factor Receptor Inhibitors and Nursing Care.Treatment of pruritus in early-stage hypopigmented mycosis fungoides with aprepitant.Advanced Care Provider and Nursing Approach to Assessment and Management of Immunotherapy-Related Dermatologic Adverse Events.
P2860
Pruritus to anticancer agents targeting the EGFR, BRAF, and CTLA-4.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pruritus to anticancer agents targeting the EGFR, BRAF, and CTLA-4.
@en
type
label
Pruritus to anticancer agents targeting the EGFR, BRAF, and CTLA-4.
@en
prefLabel
Pruritus to anticancer agents targeting the EGFR, BRAF, and CTLA-4.
@en
P2093
P2860
P356
P1433
P1476
Pruritus to anticancer agents targeting the EGFR, BRAF, and CTLA-4
@en
P2093
Alyssa Fischer
Alyx C Rosen
Courtney J Ensslin
Shenhong Wu
P2860
P304
P356
10.1111/DTH.12027
P577
2013-03-01T00:00:00Z